Telomir Pharmaceuticals TELO
NASDAQ TELO
$1.18 +0.01 (+0.85%)
At close: Oct 2, 2026 · 4:00 PM EDT

Telomir Pharmaceuticals (TELO) Interest & Investment Income (2024 - 2026)

Updated

Telomir Pharmaceuticals (TELO) reported Interest & Investment Income of $46,176 for Q2 2026, compared with $1,362 a year earlier.

Analysis

Telomir Pharmaceuticals (TELO) Interest & Investment Income (2024 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Telomir Pharmaceuticals' Interest & Investment Income came in at $163,820, up 231.9% year-over-year; for FY2025, it came in at $125,644, up 161.8% from FY2024.

  • By year, Interest & Investment Income came in at $48,000 in FY2024.
  • Five-year quarterly Interest & Investment Income spans a low of $1,362 in Q2 2025 and a high of $72,100 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Telomir Pharmaceuticals 81.15 Mn 81.15 Mn - 46,176.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 46,176.00
Dec 31, 2025 72,100.00
Sep 30, 2025 44,182.00
Jun 30, 2025 1,362.00
Dec 31, 2024 7,061.00
Sep 30, 2024 15,445.00
Jun 30, 2024 25,493.00
API Access

Telomir Pharmaceuticals Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=TELO&period=max&api_key=YOUR_API_KEY